Annual report pursuant to Section 13 and 15(d)

Stock Incentive Plan (Details Narrative)

v3.23.1
Stock Incentive Plan (Details Narrative) - USD ($)
 12 Months Ended 79 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Oct. 31, 2017
Apr. 30, 2016
Stock Option Grants Term Period 10 years        
Aggregate intrinsic value of outstanding vested stock options $ 917,798   $ 917,798    
Weighted-average exercise price $ 4.28   $ 4.28    
Unamortized unvested balance of stock base compensation $ 2,200,000   $ 2,200,000    
Unamortized unvested balance of stock base compensation, period 2 years 7 months 6 days        
Unvested restricted stock units, granted 403,522        
Aggregate intrinsic value of outstanding unvested stock options 2,690        
Weighted Average Stock Options Expected To Vest $ 4.00   $ 4.00    
Description of exercise price exercise prices ranging from $1.59 to $3.95 per share which vest over 1 to 4 years. All stock option grants have a 10-year term        
Weighted average vested exercise price $ 4.39   $ 4.39    
Stock Option Granted 604,064        
Research and Development Expenses          
Stock-based compensation expense (non-cash) $ 823,099 $ 907,737      
Minimum Member          
Risk free interest rate     0.40%    
Expected term     4 years 8 months 12 days    
Volatility     55.00%    
Maximum Member          
Risk free interest rate     4.40%    
Expected term     6 years 2 months 12 days    
Volatility     92.00%    
Stock award pool [Member]          
Share based compensation arrangement by share based payment award number of additional shares authorized 1,500,000        
2016 Stock Incentive Plan          
Share based compensation arrangement by share based payment award number of shares authorized         700,000
2016 Stock Incentive Plan | Minimum Member          
Exercise Price $ 1.59   $ 1.59    
2016 Stock Incentive Plan | Maximum Member          
Exercise Price $ 3.95   $ 3.95    
October 2017 | Board of Directors          
Share based compensation arrangement by share based payment award number of shares authorized       1,600,000  
April 2020 | Board of Directors          
Share based compensation arrangement by share based payment award number of shares authorized 3,100,000   3,100,000    
Vested 6/48ths on 6 month anniversary of grant date and 1/48th per month thereafter          
Option to purchase shares 533,552        
Vested quarterly over one year          
Option to purchase shares 60,512        
Vested monthly over one year          
Option to purchase shares 10,000        
Options [Member]          
Aggregate Stock Option Purchase Of Shares 604,064        
Research and Development Expense [Member]          
Stock-based compensation expense (non-cash) $ 818,164 $ 560,317